Navigation Links
Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan

LONDON, Aug. 24 /PRNewswire/ -- While the penetration of picture archiving and communication systems (PACS) in European hospitals is 80 per cent, the modern radiology information system (RIS) that drives PACS has only reached a penetration level of about 41 per cent. Legacy RIS modules ubiquitously dominate the market and many hospitals are reluctant to install a new RIS due to complications associated with training a large group of staff as well as concerns over data migration and security. However, with the third generation of PACS installations, hospitals have realised the importance of investing in a modern RIS. Moreover, they are also recognising the need to purchase RIS and PACS from the same vendor to reduce operational costs.



New analysis from Frost & Sullivan (, European RIS/PACS Market, finds that the market was valued at $679.4 million in 2009 and estimates this to reach $1,353.3 million in 2016.

"Expanding regulatory initiatives of DICOM and HL7 will make the homegrown RIS solution obsolete, thereby boosting RIS installations from prominent vendors," notes Frost & Sullivan Programme Manager Eramangalath Sujith. "The new slipstream of advanced PACS installations will require hospitals to have a modern RIS system that will drive these PACS."

Old RIS modules are unidirectional systems incapable of driving PACS modules. Unidirectional systems will also lead to unnecessary duplication of data, thereby adding to the operational cost of hospitals. Modern RIS and PACS installations will ensure a single-point desktop access to radiology information and digitised images. This will support enhanced productivity.

The major challenge faced by the RIS/PACS industry is related to people. Hospital staff have been used to legacy RIS modules that have existed for more than 20 years. For a long time, hospitals were only concerned with allocating budgets for PACS installations and making their IT portfolio complete.

"RIS systems used to cost as much as PACS systems about five to six years ago," explains Sujith. "European hospitals allocated budgets only for PACS purchase and not for RIS."

As most RIS and PACS modules are sold separately, hospitals can save between 10-20 per cent (depending on their preliminary requirements) of the total price on their initial RIS/PACS installation. An even more important criterion promoting system adoption is the prospect of reduced operational cost during the long term.

"Vendors for RIS and PACS modules should justify faster return on investments to clients through the purchase of both modules as a combined package," advises Sujith.

If you are interested in more information on Frost & Sullivan's latest study on the European RIS/PACS Market, please send an e-mail to Katja Feick, Corporate Communications, at, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European RIS/PACS Market is part of the Medical Imaging Growth Partnership Services programme, which also includes research in the following markets: European Laboratory Information Systems, European C-Arms Market and, Strategic Outlook into Archive Requirements for Digitised Images in Medical Imaging. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit RIS/PACS Market (M564)Contact:Katja FeickCorporate Communications – EuropeP: +49 (0) 69 7703343E: katja.feick@frost.comhttp://www.frost.comTwitter:

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
2. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
3. Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia
4. Younger Adults Increasingly Treated for Heart Disease-related Conditions
5. Increasing Dairy Milk Production with Electrolyzed Drinking Water
6. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
7. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
10. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
11. Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
Post Your Comments:
(Date:12/1/2015)... and PITTSBURGH , Dec. ... announced that it expects to be the first to ... funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate 300 ... for $99 per patient, per year. Mylan partnered with ... The significantly reduced price could generate savings of tens ...
(Date:12/1/2015)... Dec. 1, 2015  Six months of adjunctive metformin therapy ... 1 diabetes, according to new research from T1D Exchange ... may have a beneficial effect on measures of obesity, including ... of the Journal of the American Medical Association , ... effect of metformin on overweight and obese adolescents with type ...
(Date:12/1/2015)... 2015 ... of the "2016 Europe Enteric ... Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, ... offering. --> ) ... "2016 Europe Enteric Disease Testing ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 ... of the company’s growing product line of food safety and seafood fraud prevention ... (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for the ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... of non-traumatic limb amputations in the United States. Podiatrists are well aware that ... to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Center of Excellence (BHCOE) today announced that the organization has awarded Education and ... Francisco, with a Distinguished Award. The award celebrates exceptional special needs providers that ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
(Date:12/1/2015)... Beverly Hills, CA (PRWEB) , ... December 01, ... ... honored by Modern Luxury’s Angeleno Magazine as a Modern Man for 2015. ... luxury lifestyle publisher in the United States. Established in 1994, Modern Luxury includes ...
Breaking Medicine News(10 mins):